![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Teleflex Recalls Its Percutaneous Thrombolytic Device Due to Lumen Detaching
Teleflex Recalls Its Percutaneous Thrombolytic Device Due to Lumen Detaching
The FDA has deemed Teleflex’s worldwide recall of its Arrow-Trerotola over-the-wire percutaneous thrombolytic device kit to be a class I recall because there is “a reasonable probability that the use of or exposure to [the] product will cause serious adverse health consequences or death.”
The recall followed reports indicating that the inner lumen may detach from the device’s basket, the Wayne, Pa.-based company said. Four products that were manufactured from October 2019 through July, a total of 53 lots, are covered in the recall.
The company has received seven customer complaints about the problem so far, but said no long-term patient complications have been reported.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct